產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-Phospho-Bcl-2 (Thr56)抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-Phospho-Bcl-2 (Thr56)抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-Phospho-Bcl-2 (Thr56)
Cat. Number:
Anti-Phospho-Bcl-2 (Thr56)抗體KL-3053R
Quantity size:
0.1ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
BCL2 is an integral outer mitochondrial membrane protein that blocks the apoptotic death of some cells such as lymphocytes. Constitutive expression of BCL2, such as in the case of translocation of BCL2 to Ig heavy chain Anti-Phospho-Bcl-2 (Thr56)抗體locus, is thought to be the cause of follicular lymphoma. Two transcript variants (alpha and beta) produced by alternate splicing, differ in their C-terminal ends. BCL2 suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. It regulates cell death by controlling the mitochondrial membrane permeability. It appears to function in a feedback loop system with caspases. BCL2 inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF1). It can form homodimers, and heterodimers with BAX, BAD, BAK and BclX(L). Heterodimerization with BAX requires intact BH1 and BH2 domains, and is necessary for anti-apoptotic activity. Also interacts with APAF1, RAF1, TP53BP2, BBC3, BCL2L1 and BNIPL.
Also known as:
Bcl2 (phospho T56); Anti-Phospho-Bcl-2 (Thr56)抗體Bcl2 (phospho Thr56); p-Bcl2 (phospho T56); Apoptosis regulator Bcl 2; Apoptosis regulator Bcl2; AW986256; B cell CLL/lymphoma 2; B cell leukemia/lymphoma 2; B cell lymphoma 2; Bcl 2; Bcl-2; Bcl2; BCL2 protein; C430015F12Rik; D630044D05Rik; D830018M01Rik; Leukemia/lymphoma, B-cell, 2; Oncogene B-cell leukemia 2; BCL2_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, .
●
Immunogen: KLH conjugated Synthesised phosphopeptide derived from human Bcl-2 around the phosphorylation site of Thr56.
●
Predicted Molecular Weight: 26kDa.
Storage:
Shipped at 4℃, Store Anti-Phospho-Bcl-2 (Thr56)抗體at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working Anti-Phospho-Bcl-2 (Thr56)抗體dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working Anti-Phospho-Bcl-2 (Thr56)抗體dilutions must be determined by the end user.
kl058Ga01 白介素12B(IL12B)多克隆抗體 Polyclonal Antibody to Interleukin 12B (IL12B)
kl058Gu01 白介素12B(IL12B)多克隆抗體 Polyclonal Antibody to Interleukin 12B (IL12B)
kl058Hu01 白介素12B(IL12B)多克隆抗體 Polyclonal Antibody to Interleukin 12B (IL12B)
kl058Mu01 白介素12B(IL12B)多克隆抗體 Polyclonal Antibody to Interleukin 12B (IL12B)
kl058Po01 白介素12B(IL12B)多克隆抗體 Polyclonal Antibody to Interleukin 12B (IL12B)
kl058Ra01 白介素12B(IL12B)多克隆抗體 Polyclonal Antibody to Interleukin 12B (IL12B)
kl059Bo01 白介素12A(IL12A)多克隆抗體 Polyclonal Antibody to Interleukin 12A (IL12A)
kl059Ca01 白介素12A(IL12A)多克隆抗體 Polyclonal Antibody to Interleukin 12A (IL12A)
kl059Cp01 白介素12A(IL12A)多克隆抗體 Polyclonal Antibody to Interleukin 12A (IL12A)
kl059Eq01 白介素12A(IL12A)多克隆抗體 Polyclonal Antibody to Interleukin 12A (IL12A)
kl059Ga01 白介素12A(IL12A)多克隆抗體 Polyclonal Antibody to Interleukin 12A (IL12A)
kl059Hu01 白介素12A(IL12A)多克隆抗體 Polyclonal Antibody to Interleukin 12A (IL12A)
kl059Mu01 白介素12A(IL12A)多克隆抗體 Polyclonal Antibody to Interleukin 12A (IL12A)
kl059Po01 白介素12A(IL12A)多克隆抗體 Polyclonal Antibody to Interleukin 12A (IL12A)
kl059Ra01 白介素12A(IL12A)多克隆抗體 Polyclonal Antibody to Interleukin 12A (IL12A)
kl060Bo01 白介素13(IL13)多克隆抗體 Polyclonal Antibody to Interleukin 13 (IL13)
kl060Ca01 白介素13(IL13)多克隆抗體 Polyclonal Antibody to Interleukin 13 (IL13)
kl060Cp01 白介素13(IL13)多克隆抗體 Polyclonal Antibody to Interleukin 13 (IL13)
